BCG vaccine in insulin-dependent diabetes mellitus. IMDIAB Group

Lancet. 1997 May 24;349(9064):1520-1. doi: 10.1016/s0140-6736(05)62100-9.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • BCG Vaccine / administration & dosage
  • BCG Vaccine / therapeutic use*
  • Blood Glucose / analysis
  • C-Peptide / blood
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 1 / therapy*
  • Follow-Up Studies
  • Glycated Hemoglobin / analysis
  • Humans
  • Injections, Intradermal
  • Insulin / administration & dosage
  • Insulin / blood
  • Insulin / therapeutic use
  • Niacinamide / administration & dosage
  • Niacinamide / therapeutic use
  • Remission Induction

Substances

  • BCG Vaccine
  • Blood Glucose
  • C-Peptide
  • Glycated Hemoglobin A
  • Insulin
  • Niacinamide